Cancer and Gene Regulation

Core Concepts

The cell cycle and its checkpoints

Cell division is governed by the cell cycle, whose transitions are driven by cyclins and cyclin-dependent kinases (CDKs). Checkpoints pause the cycle when problems are detected: the G1/S checkpoint checks conditions before DNA is copied, the G2/M checkpoint verifies replication was damage-free, and the M checkpoint confirms chromosomes are attached correctly. Two tumor suppressors police these gates:

• Rb (retinoblastoma protein) holds the G1→S brake: while active, it keeps cells from entering S phase; when phosphorylated by cyclin–CDK complexes, it releases and allows division.
• p53, often called the "guardian of the genome," responds to DNA damage: it halts the cycle at G1 to allow repair, or, if damage is beyond repair, triggers apoptosis — programmed cell death. p53 also activates DNA-repair genes.

Proto-oncogenes → oncogenes: the stuck accelerator

A proto-oncogene is a normal gene that promotes growth (growth factors, their receptors, signaling kinases like Ras, or transcription factors like Myc). A mutation that makes it permanently active converts it into an oncogene. Because one altered copy is enough to push the cell toward growth, oncogene mutations are dominant at the cellular level. Activation happens in several ways:

• Point mutation: a single amino acid change locks the protein "on" — the classic example is a Ras mutation that prevents the protein from turning itself off, so growth signals fire continuously.
• Gene amplification: extra copies of the gene mean more protein.
• Chromosomal translocation: moving a growth gene next to a strong promoter creates a fusion protein or overexpression — the BCR-ABL fusion on the Philadelphia chromosome in chronic myeloid leukemia is the classic teaching example.
• Overexpression driven by misplaced enhancers.

Tumor suppressors: the broken brakes

Tumor suppressor genes normally restrain division, promote repair, or trigger death. Unlike oncogenes, they usually require both copies to be lost or inactivated before the protective effect disappears — a loss of function that behaves recessively at the cellular level. The two-hit hypothesis (Knudson's model, from retinoblastoma) explains inherited cancer risk: if a child inherits one defective copy of RB1, every cell starts with one "hit"; a single somatic mutation in any cell delivers the second hit, so tumors arise early and often. A person with two normal copies needs two independent somatic hits in the same cell — far less likely, which is why sporadic retinoblastoma is rare and later-onset.

Apoptosis: the fail-safe that must also fail

Even with a broken cell cycle, a cell can still die by apoptosis — orderly, programmed cell death. The decision is controlled by the Bcl-2 family: pro-apoptotic members (like Bax) promote death by making mitochondrial membranes leaky, while anti-apoptotic members (like Bcl-2) block them. Cancer cells frequently disable apoptosis — by losing p53, overexpressing Bcl-2, or both — so they survive stresses that should kill them. Many chemotherapies work precisely by pushing cancer cells back toward apoptosis.

Cancer is a multistep process

A single mutation does not cause cancer. Tumor formation requires an accumulation of mutations — typically in oncogenes, tumor suppressors, apoptosis regulators, and DNA-repair genes — plus the hallmarks that follow: sustained growth signaling, evasion of death, angiogenesis (recruiting new blood vessels), invasion, and metastasis (spreading to other tissues). The classic teaching model is colorectal cancer: a series of mutations in genes like APC (tumor suppressor), Ras (oncogene), and p53 (tumor suppressor) accompanies the progression from benign polyp to invasive carcinoma. Because mutations accumulate over a lifetime of cell divisions, cancer risk rises with age — and the disease is a failure of regulation at every level of this chapter, from epigenetic silencing (Topic 3) to the destruction of p53 by the ubiquitin system (Topic 6).

Common Confusions